Skip to Main Content

Paper Details

The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development.
Clin Cancer Res
50
2020
Cancer, ERG, MDA PCa, MDA PCa 2a and 2b, MDA PCa PDX, MDA PCa PDX series, PDX, PDX series, PDXs, PTEN, Patient, Prostate Cancer, SPOP, SPOP mutations, SPOP paralog, SPOPL, androgen, androgen receptor, cell line, cell lines, human, patient, prostate cancer, prostate cancers, speckle-type POZ protein-like, speckle-type POZ protein-like (SPOPL) gene, tumor
Author NameAffiliation
Nallasivam PalanisamyVattikuti Urology Institute
Nallasivam PalanisamyMichigan Center for Translational Pathology, University of Michigan ann arbor
Ganiraju C ManyamThe University of Texas MD Anderson Cancer Center
Eleni EfstathiouDepartment of Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center
Scott A TomlinsMichigan Center for Translational Pathology, University of Michigan ann arbor
Lakshmi P KunjuMichigan Center for Translational Pathology, University of Michigan ann arbor
Arul M ChinnaiyanMichigan Center for Translational Pathology, University of Michigan ann arbor
Arul M ChinnaiyanMichigan Center for Translational Pathology, University of Michigan ann arbor
Nora M NavoneDepartment of Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center
  • 1 - 9

Datasets

Release 1.2